peritoneal cavity chemotherapy

Objective: To study the clinical effect of primary hepatocarcinoma treated by interventional therapy combined with peritoneal cavity chemotherapy, and to evaluate the immunological function of patients. The side reaction of interventional therapy and peritoneal cavity chemotherapy was studied.
目的：探討介入治療聯(lián)合腹腔化療對原發(fā)性肝癌的臨床療效，對患者的免疫功能進行客觀的評價，同時對介入治療和介入治療聯(lián)合腹腔化療兩種治療方案的毒副反應(yīng)進行對比研究，進一步探討血管造影、碘油沉積情況與預(yù)后的關(guān)系。